SPARC enters into licensing deal with CMS to develop and commercialise products EP News Bureau Nov 6, 2019 The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…
Biocon licenses three generic formulation products to China Medical System Holdings EP News Bureau Sep 13, 2019 Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products…
Sun Pharma and CMS enter into a License Agreement for Cyclosporine A and Tildrakizumab in Greater… EP News Bureau Jun 27, 2019 Under the terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone…
